Oxford Biomedica plc (FRA:OXOA)
9.45
-0.25 (-2.58%)
At close: Jan 30, 2026
Oxford Biomedica Revenue
Oxford Biomedica had revenue of 73.22M GBP in the half year ending June 30, 2025, with 70.04% growth. This brings the company's revenue in the last twelve months to 151.21M, up 55.44% year-over-year. In the year 2024, Oxford Biomedica had annual revenue of 128.80M with 43.84% growth.
Revenue (ttm)
151.21M GBP
Revenue Growth
+55.44%
P/S Ratio
6.57
Revenue / Employee
168.02K GBP
Employees
900
Market Cap
1.16B EUR
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 128.80M | 39.26M | 43.84% |
| Dec 31, 2023 | 89.54M | -50.45M | -36.04% |
| Dec 31, 2022 | 139.99M | -2.81M | -1.97% |
| Dec 31, 2021 | 142.80M | 55.07M | 62.77% |
| Dec 31, 2020 | 87.73M | 23.67M | 36.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gelsenwasser AG | 3.36B |
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| tonies SE | 510.38M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |